Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Yasa Motors
YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.
Incorporated in August 2009
Origin: Oxford University, Department of Engineering Science
CN Bio Innovations
Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.
Incorporated in July 2009
Origin: Oxford University, Institute of Biomedical Engineering
Oxford Financial Computing
2008
Organox
The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation. The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs.
Incorporated in November 2008
Origin: Oxford University, Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences
Loop (Nevatas)
Navetas is a UK based technology company delivering cloud-based energy monitoring and smart data analytics for the connected home.
Incorporated in November 2008
Origin: Oxford University, Department of Engineering Science
Oxford Emergent TB Consortium Ltd
Semmle
SemmleCode is a line of products aimed to help developer teams improve their software quality.
Incorporated in March 2008
Origin: Oxford University, Department of Computer Science
2007
Adaptimmune
Developing immunotherapies that can potentially transform cancer treatment.
Incorporated in December 2007
Origin: Oxford University
Crysalin
Oxford Biodynamics
Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression.
Incorporated in June 2007
Origin: Oxford University, Department of Pathology
Clinox
ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.
Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences
Fuel 3D (Eykona)
Eykona develops state-of-the-art imaging solutions to capture dermal characteristics and shape from the human body.
Incorporated in February 2007
Origin: Oxford University, Department of Engineering Science
2006
Alcolizer Technology UK (OxTox)
Cytox
Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias.
Incorporated in October 2006
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
Oxford Advanced Surfaces
Oxford Advanced Surfaces develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.
Incorporated in September 2006
Origin: Oxford University, Department of Chemistry
Aurox
Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.
Incorporated in July 2006
Origin: Oxford University, Department of Engineering Science
Particle Therapeutics
Deepmatter (Cronin Group – OAS)
Big data and analysis company focused on enabling reproducibility in chemistry.
Incorporated in June 2006
Origin: Oxford University
Oxford Medistress
Oxford Medistress is commercialising a novel in vitro blood test device which aims to provide the first objective, quantitative measurement of stress.
Incorporated in April 2006
Origin: Oxford University, Department of Zoology
TDeltaS
TdeltaS is committed to developing science-based proprietary products that sit at the interface of food and pharmaceuticals - nutraceuticals - and offer real improvement in human physical and mental performance.
Incorporated in March 2006
Origin: Oxford University, Department of Physiology, Anatomy and Genetics